Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 261 publications
BPI26-018: Integrated Specialty Prostate Cancer Care: Outcomes From a Collaborative Clinic Model at UC San Diego Moores Cancer Center.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 29, 2026
Noninvasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Multisite Validation and Comparison with MRI.
Journal: The Journal of urology
Published: April 28, 2026
Trial protocol: RadTARGET, a multicenter phase II randomized controlled trial evaluating focal radiotherapy boost with de-intensification of dose to non-suspicious prostate in patients with intermediate- or high-risk prostate cancer.
Journal: Clinical and translational radiation oncology
Published: April 26, 2026
Combining Serum PVT1 Exon 4A and Exon 9 with Serum Prostate-Specific Antigen Shows Potential for Improving Identification and Risk Stratification of Prostate Cancer.
Journal: Cancer management and research
Published: April 03, 2026
BPI26-018: Integrated Specialty Prostate Cancer Care: Outcomes From a Collaborative Clinic Model at UC San Diego Moores Cancer Center.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 01, 2026
Impact of Elevated C-Reactive Protein on Survival Outcomes of Patients with Small Renal Masses: A Retrospective Multicenter Analysis.
Journal: Current oncology (Toronto, Ont.)
Published: March 23, 2026
Detection and Localization of Unfavorable-histology Prostate Cancer Using MRI and Whole-mount Histopathology.
Journal: European urology oncology
Published: March 03, 2026
Deep Learning Artificial Intelligence and Restriction Spectrum Imaging for Patient-level Detection of Clinically Significant Prostate Cancer on Biparametric Magnetic Resonance Imaging.
Journal: European urology open science
Published: January 23, 2026
Killing cancer takes guts: lessons learned from the manipulation of gut microbiome and immunotherapy for the future of urothelial carcinoma.
Journal: Oncoimmunology
Published: January 21, 2026
Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer: a phase 3, multicentre, randomised, double-blind, placebo-controlled trial.
Journal: The Lancet. Oncology
Published: January 06, 2026
Systematic effects of patient factors and scanner/protocol factors on a Restriction Spectrum Imaging (RSI) quantitative MRI biomarker for prostate cancer.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: December 31, 2025
Last Updated: 09/26/2026